{"id":"W4386499275","doi":"10.1038/s41591-023-02543-w","title":"Senolytic therapy in mild Alzheimer’s disease: a phase 1 feasibility trial","year":2023,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Alzheimer's disease research and treatments","field":"Medicine","cited_by":247,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Institute of Neurological Disorders and Stroke; University of Texas Health Science Center at San Antonio; National Heart, Lung, and Blood Institute; Cure Alzheimer's Fund; Noaber Foundation; McGill University; National Heart and Lung Institute; Alzheimer's Drug Discovery Foundation; American Federation for Aging Research; U.S. Department of Veterans Affairs; U.S. Department of Health and Human Services; National Institute on Aging; Hevolution Foundation; Alzheimer's Association; GHR Foundation","keywords":"Medicine; Disease; Clinical trial; Alzheimer's disease; Oncology; Internal medicine","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006724375,0.0003215439,0.0006372054,0.0005206311,0.00008890301,0.0000103988,0.0001677519,0.0002622208,0.0006956747],"category_scores_gemma":[0.0006980929,0.0002118645,0.0001758428,0.00145273,0.0002615621,0.00008458054,0.0000495076,0.00097078,0.0002154829],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001442971,"about_ca_system_score_gemma":0.0004936741,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006539573,"about_ca_topic_score_gemma":0.00001530152,"domain_scores_codex":[0.9969441,0.0001597812,0.0004219503,0.0006356389,0.001167034,0.0006715508],"domain_scores_gemma":[0.9978226,0.0002587851,0.00007277117,0.0007402562,0.0001454335,0.0009601117],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6546159,0.01418326,0.1418265,0.0003385021,0.01275,0.01694093,0.00101373,0.000003642879,0.0008301422,0.0004433061,0.09171225,0.06534191],"study_design_scores_gemma":[0.6401934,0.008616255,0.3378159,0.0007376425,0.001654192,0.00003186664,0.000249954,0.0007282104,0.0005852785,0.001829704,0.007079423,0.0004782018],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9116036,0.07039684,0.000001209388,0.01292444,0.0004704943,0.003277846,0.00006550619,0.0002516769,0.001008442],"genre_scores_gemma":[0.994712,0.00198054,0.0000190723,0.001174145,0.00100797,0.0002078123,0.0006679498,0.0000465306,0.0001839827],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1959894,"threshold_uncertainty_score":0.8639582,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1105407341117418,"score_gpt":0.4508168843221032,"score_spread":0.3402761502103614,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}